Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 1/24/2026Recent Executive Moves
  • 1/23/2026China Grants Conditional Approval to First Hepatitis D Treatment
  • 1/23/2026Fosun Pharma Moves to Spin Off Vaccine Unit for Hong Kong IPO
  • 1/23/2026Livzon Moves to Acquire Majority Stake in Vietnam's Imexpharm
  • 1/23/2026CDE Seeks Public Feedback on Draft ICH E22 Guideline on Patient Prefer...
  • 1/23/2026CDE Invites Public Comment on Draft Guideline for Physicochemical and ...
  • 1/23/2026Mabwell Advances CDH17 ADC Program with First U.S. Patient Dosed
  • 1/23/2026Insilicon Secures FDA IND Clearance for Oral NLRP3 Inhibitor ISM8969
  • 1/23/2026Gene Key Secures Over CNY 100M to Accelerate iNKT Cell Therapy Develop...
  • 1/22/2026Henlius Gains NMPA Green Light for Phase 1b/2 Trial of HLX701
  • 1/22/2026China Companion Animal Health Market to Reach US$ 3.7B by 2030
  • 1/22/2026Hua Medicine Targets Global Diabetes Growth with Non-GLP-1 Strategy
  • 1/22/2026Corxel Raises Up to $287M to Push GLP-1 Pill Toward Global Markets
  • 1/22/2026China Unveils New Policy to Transform Pharmacies into Community Health...
  • 1/22/2026CDE Seeks Public Input on Draft Guidance for Risk Assessment and Contr...
  • 1/22/2026NMPA Issues New Guidance to Standardize Vaccine Adjuvant Research, Boo...
  • 1/22/2026Bangshun Pharma Files for Hong Kong IPO
  • 1/22/2026Genmab Halts Development of Three China-Originated Oncology Assets fro...
  • 1/22/2026T-MAXIMUM Unveils First Human Data for CRISPR-Edited CAR-T
  • 1/22/2026Daiichi Sankyo Wins New China Approval for Enhertu
  • 1/22/2026AbbVie Secures China Approval for Skyrizi in Ulcerative Colitis
  • 1/22/2026Juncell Unveils Phase I TIL Data for Advanced NSCLC as IPO Push Accele...
  • 1/21/2026China Launches Clinical Trial of First Acne Vaccine Candidate
  • 1/21/2026Pomdoctor Deepens Pharma Partnerships to Drive Internet Hospital Expan...
  • 1/21/2026CDE Issues Draft Guidance on Using Bayesian External Data in Drug Clin...
  • 1/21/2026Roche Advances Oral GLP-1 Program as RO7795081 Cleared for China Clini...
  • 1/21/2026Pfizer Pulls Back on Mesothelin-Targeting ADC Sublicensed from Harbour...
  • 1/21/2026NewDEL Raises A+ Round Led by XtalPi to Accelerate DEL-AI Drug Develop...
  • 1/21/2026Telix Advances China Strategy as Prostate Cancer Imaging Filing Clears...
  • 1/21/2026Harbour BioMed Takes Strategic Stake in Spruce Biosciences
  • Page:1/59 Total number of articles:1746: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group